Patterns of Daily Practice of Hormone Therapy in Unfavorable and Favorable Intermediate-Risk Prostate Cancer: Results of the French PROACT Survey

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2017.06.1113
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Ultra-Hypofractionated Radiation Therapy for Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Is Safe and Effective: 5-Year Outcomes of a Phase II Trial

BJU International
Urology
2019English

Mp18-07 Applicability Analysis of Focal Therapy to Intermediate- And High-Risk Prostate Cancer

Journal of Urology
Urology
2016English

Evaluation of the Effectiveness of Adding Androgen Deprivation to Modern Dose-Escalated Radiotherapy for Men With Favorable Intermediate-Risk Prostate Cancer

Cancer
Cancer ResearchOncology
2016English

Race and the Risk of Death Following High-Dose Radiation Therapy in Men Treated With or Without Androgen Suppression Therapy for Favorable-Risk Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Intermediate Risk Prostate Cancer Patients Treated With Image Guided Hypofractionated Radiation Therapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Hypofractionated Stereotactic Body Radiation Therapy as Monotherapy for Intermediate-Risk Prostate Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2013English

Selection Criteria for Initiation and Renewal of Luteinizing Hormone-Releasing Hormone Agonist Therapy in Patients With Prostate Cancer: A French Prospective Observational Study

Therapeutic Advances in Urology
Urology
2014English

Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Risk Stratification for Intermediate- And High-Risk Patients

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Use of Androgen Deprivation Therapy With Radiotherapy for Intermediate- And High-Risk Prostate Cancer Across the United States

JAMA Oncology
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy